Wenda Wu Selected Research

Wenda Wu Research Topics

Disease

13	Vomiting 08/2023 - 01/2013
12	Anorexia 12/2022 - 08/2011
11	Hypoxia (Hypoxemia) 09/2023 - 01/2020
11	Neoplasms (Cancer) 07/2023 - 10/2018
8	Foodborne Diseases 01/2022 - 01/2013
5	Infections 12/2023 - 10/2018
3	Poisoning 11/2023 - 01/2021
3	Inflammation (Inflammations) 01/2022 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2023 - 01/2022
2	COVID-19 07/2022 - 01/2022
2	Body Weight (Weight, Body) 10/2021 - 01/2018
1	Pain (Aches) 04/2024
1	Bites and Stings (Sting) 12/2023
1	Hypercholesterolemia 11/2023
1	Immune System Diseases (Immune Disorders) 09/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	Aflatoxin Poisoning 11/2022
1	Type 2 Diabetes Mellitus (MODY) 07/2022
1	Kashin-Beck Disease 06/2022
1	Carcinogenesis 02/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Hemorrhage 01/2022
1	Amyloid Plaque 01/2022

Drug/Important Bio-Agent (IBA)

21	MycotoxinsIBA 09/2023 - 01/2013
17	deoxynivalenolIBA 12/2023 - 08/2011
13	T-2 Toxin (T 2 Toxin)IBA 10/2022 - 04/2016
12	trichotheceneIBA 08/2023 - 01/2013
7	Serotonin (5 Hydroxytryptamine)IBA 08/2023 - 05/2013
7	TrichothecenesIBA 04/2023 - 11/2017
7	Hormones (Hormone)IBA 01/2022 - 05/2013
6	Peptides (Polypeptides)IBA 11/2023 - 04/2014
6	EmeticsIBA 01/2022 - 01/2013
5	Neurotransmitter Agents (Neurotransmitter)IBA 08/2023 - 05/2013
5	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2022 - 11/2017
5	CytokinesIBA 01/2022 - 01/2014
5	amsonic acid (DAS)IBA 01/2020 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2020
4	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 08/2023 - 05/2013
4	Granisetron (Kytril)FDA LinkGeneric 08/2023 - 05/2013
4	neuropeptide Y2 receptorIBA 08/2023 - 05/2013
4	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 01/2017
4	diacetoxyscirpenolIBA 01/2020 - 01/2017
4	Cholecystokinin (Pancreozymin)IBA 05/2018 - 05/2013
4	peptide YY (3-36)IBA 01/2018 - 05/2013
4	HT-2 toxinIBA 11/2017 - 04/2016
3	Type B TrichothecenesIBA 12/2022 - 04/2016
3	Glucagon (Glukagon)FDA Link 01/2022 - 11/2017
3	JNK Mitogen-Activated Protein KinasesIBA 01/2022 - 11/2019
3	Appetite Depressants (Anorectics)IBA 05/2018 - 11/2014
3	Type A TrichothecenesIBA 01/2018 - 04/2016
3	Peptide Hormones (Polypeptide Hormones)IBA 01/2017 - 05/2013
3	fusarenon-XIBA 08/2016 - 01/2013
3	15-acetyldeoxynivalenolIBA 08/2016 - 01/2013
3	nivalenolIBA 08/2016 - 01/2013
3	3-acetyldeoxynivalenolIBA 08/2016 - 01/2013
2	Peptide YYIBA 08/2023 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2023 - 01/2021
2	AflatoxinsIBA 04/2023 - 10/2021
2	Messenger RNA (mRNA)IBA 01/2023 - 01/2014
2	Chloroquine (Aralen)FDA LinkGeneric 07/2022 - 01/2022
2	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2022 - 01/2021
2	Ruthenium RedIBA 01/2022 - 01/2022
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2014
2	SR 27897 (Lintitript)IBA 05/2018 - 04/2014
2	Cholecystokinin B ReceptorIBA 05/2018 - 04/2014
2	AmidesIBA 05/2018 - 11/2017
2	neosolaniolIBA 11/2017 - 01/2017
1	Fentanyl (Sublimaze)FDA LinkGeneric 04/2024
1	Opioid Receptors (Opioid Receptor)IBA 04/2024
1	Morphine (MS Contin)FDA LinkGeneric 04/2024
1	Interferon Type IIBA 12/2023
1	Antiviral Agents (Antivirals)IBA 12/2023
1	ConnectinIBA 11/2023
1	oxidized low density lipoproteinIBA 11/2023
1	Nerve AgentsIBA 11/2023
1	AcetylcholinesteraseIBA 11/2023
1	Apolipoproteins E (ApoE)IBA 11/2023
1	CholesterolIBA 11/2023
1	Obidoxime Chloride (Obidoxime)IBA 11/2023
1	PesticidesIBA 11/2023
1	Trimedoxime (Trimedoxime Bromide)IBA 11/2023
1	MicroRNAs (MicroRNA)IBA 09/2023
1	AntioxidantsIBA 11/2022
1	OccludinIBA 10/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2022
1	Arsenic Trioxide (Trisenox)FDA Link 10/2022
1	CateninsIBA 10/2022
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 10/2022
1	jugloneIBA 10/2022
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 10/2022
1	Claudin-1IBA 10/2022
1	VaccinesIBA 10/2022
1	chloroquine diphosphate FDA LinkGeneric 07/2022
1	Aggrecans (Aggrecan)IBA 06/2022
1	Stem Cell FactorIBA 01/2022

Therapy/Procedure

5	Therapeutics 10/2022 - 10/2018
3	Oral Administration 04/2016 - 01/2013
2	Immunotherapy 01/2022 - 01/2021